EpCAM as a novel therapeutic target for hepatocellular carcinoma
Author:
Publisher
Journal of Oncological Sciences (JOS)
Reference56 articles.
1. Trends in cancer incidence in esophagus, stomach, colon, rectum and liver in males in India;Yeole;Asian Pac J Cancer Prev,2008
2. Hepatocellular carcinoma in the Asia-Pacific region;Zhu;Gut Liver,2016
3. Expression of EpCAM increases in the hepatitis B related and the treatment-resistant hepatocellular carcinoma;Kimura;BioMed Res Int Volume,2014
4. Sorafenib for the treatment of unresectable hepatocellular carcinoma;Kane;Oncol,2009
5. Liver cancer stem cells: implications for a new therapeutic target;Lee;Liver Int,2009
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Detection of Hepatocellular Carcinoma in an Orthotopic Patient-Derived Xenograft with an Epithelial Cell Adhesion Molecule-Specific Peptide;Cancers;2024-08-10
2. The Role of Epithelial Cell Adhesion Molecule Cancer Stem Cell Marker in Evaluation of Hepatocellular Carcinoma;Medicina;2024-05-30
3. Hybridized quantum dot, silica, and gold nanoparticles for targeted chemo-radiotherapy in colorectal cancer theranostics;Communications Biology;2024-04-01
4. Targeting liver cancer stem cell through EpCAM therapy targeted with chemotherapy endorse enhanced progression in hepatocellular carcinoma;Egyptian Liver Journal;2023-06-16
5. Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma;World Journal of Gastroenterology;2023-05-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3